拉抬打压股价等多项行为违规，这家私募被出具警示函，实控人曾是财经评论员

Core Viewpoint - Zhejiang Haokun Shengfa Asset Management Co., Ltd. has been issued a warning letter by the Zhejiang Securities Regulatory Bureau due to multiple violations, including unfair treatment of different fund assets and misleading promotional materials for private funds [1][2][3] Group 1: Violations and Regulatory Actions - The company has been found to engage in unfair treatment of different fund assets, misleading statements in promotional materials, and reverse trading without decision-making records [2][3] - The legal representative and general manager, Zhang Menfa, along with the actual management personnel and fund manager, Ge Zhongfu, have also received warning letters as part of supervisory measures [1][3] - These actions violate the "Interim Measures for the Supervision and Administration of Private Investment Funds," leading to the issuance of a warning letter and recording in the securities and futures market integrity archive [3] Group 2: Market Manipulation Concerns - The behavior of price manipulation through intra-day price lifting and suppression is considered market manipulation, which undermines the principles of fairness and transparency in the market [4] - Such actions distort market pricing mechanisms, mislead investor decisions, and can lead to unnecessary losses for investors [4] - Regulatory measures are suggested to enhance monitoring through technology, utilizing big data to track fund movements, and increasing administrative penalties and criminal accountability [4] Group 3: Fund Performance and Holdings - In the third quarter, multiple products from Zhejiang Haokun Shengfa Asset appeared among the top ten circulating shareholders of several stocks on the Beijing Stock Exchange, including Jiahua Technology and Henghe Shares [5][6] - Specific holdings include 727,500 shares in Hongyu Packaging and significant positions in Jin Hao Medical, which has seen a price increase of over 203% this year [6]